Target-based molecular signature characteristics of cervical adenocarcinoma and squamous cell carcinoma

International Journal of Oncology

Volumn 43, Issue 2, 2013, Pages 539-547

  Kim, Yong Wan ^a   Bae, Su Mi ^a   Kim, Yong Wook ^a   Park, Dong Choon ^b   Lee, Keun Ho ^b   Liu, Hai Bo ^a   Kim, In Wook ^a   Jang, Chun Keun ^a   Ahn, Woong Shick ^b  

^a Bupyeong gu   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Adenocarcinoma; Cervical cancer; Microarray analysis; Molecular interaction networks; Squamous cell carcinoma

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; KRT17 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1;

APOPTOSIS; ARTICLE; CANCER CLASSIFICATION; CARCINOGENESIS; CELL DEATH; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA DAMAGE; DNA DAMAGE CHECKPOINT; DNA REPLICATION; ENZYME ACTIVITY; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; METAPLASIA; MICROARRAY ANALYSIS; NERVE CELL; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS VULGARIS; SPLENOMEGALY; UTERINE CERVIX; UTERINE CERVIX ADENOCARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERUS MYOMA;

ADENOCARCINOMA; CALCITONIN; CARCINOMA, SQUAMOUS CELL; DOWN-REGULATION; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; KERATIN-17; PPAR GAMMA; PROTEIN PRECURSORS; RECEPTOR, IGF TYPE 1; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 84879639254     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1961     Document Type: Article

References (34)

1. Bulk S, Visser O, Rozendaal L, Verheijen RH and Meijer CJ: Cervical cancer in the Netherlands 1989-1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer 113: 1005-1009, 2005. (Pubitemid 40096882)
2. International Collaboration of Epidemiological Studies of Cervical Cancer: Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 120: 885-891, 2007.
3. Ciapponi A, Bardach A, Glujovsky D, Gibbons L and Picconi MA: Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis. PLoS One 6: e25493, 2011.
4. Clifford GM, Smith JS, Plummer M, Munoz N and Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88: 63-73, 2003.
5. Castellsague X, Diaz M, de Sanjose S, et al: Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 98: 303-315, 2006. (Pubitemid 43338210)
6. Plummer M, Herrero R, Franceschi S, et al: Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control 14: 805-814, 2003. (Pubitemid 37500732)
7. Wingo SN, Gallardo TD, Akbay EA, et al: Somatic LKB1 mutations promote cervical cancer progression. PLoS One 4: e5137, 2009.
8. Wessels JM, Edwards AK, Zettler C and Tayade C: Selection and validation of reference genes for miRNA expression studies during porcine pregnancy. PLoS One 6: e28940, 2011.
9. Yang IV, Chen E, Hasseman JP, et al: Within the fold: assessing differential expression measures and reproducibility in microarray assays. Genome Biol 3: research0062, 2002.
10. Bae SM, Lee CH, Cho YL, et al: Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol Oncol 99: 26-35, 2005. (Pubitemid 41354579)
11. Smedts F, Ramaekers F, Troyanovsky S, et al: Basal-cell keratins in cervical reserve cells and a comparison to their expression in cervical intraepithelial neoplasia. Am J Pathol 140: 601-612, 1992.
12. Zumkeller W: IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth? Mol Pathol 54: 285-288, 2001.
13. Reubi JC: In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging. J Nucl Med 36: 1846-1853, 1995.
14. Nakanuma Y, Kouda W, Nakano T, Uneno K, Tachibana S and Araki I: A case report of early idiopathic portal hypertension. Pathol Res Pract 197: 759-767, 2001.
15. Iizuka N, Oka M, Yamada-Okabe H, et al: Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res 62: 3939-3944, 2002. (Pubitemid 34791056)
16. Wyllie AH: Apoptosis and carcinogenesis. Eur J Cell Biol 73: 189-197, 1997.
17. Dixon BP, Henry J, Siroky BJ, Chu A, Groen PA and Bissler JJ: Cell cycle control and DNA damage response of conditionally immortalized urothelial cells. PLoS One 6: e16595, 2011.
18. Luk SC, Siu SW, Lai CK, Wu YJ and Pang SF: Cell cycle arrest by a natural product via G2/M checkpoint. Int J Med Sci 2: 64-69, 2005. (Pubitemid 40944955)
19. Choi HJ, Fukui M and Zhu BT: Role of cyclin B1/Cdc2 up-regulation in the development of mitotic prometaphase arrest in human breast cancer cells treated with nocodazole. PLoS One 6: e24312, 2011.
20. Gao Q, Srinivasan S, Boyer SN, Wazer DE and Band V: The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation. Mol Cell Biol 19: 733-744, 1999. (Pubitemid 29018474)
21. Arai H, Ueno T, Tangoku A, et al: Detection of amplified oncogenes by genome DNA microarrays in human primary esophageal squamous cell carcinoma: comparison with conventional comparative genomic hybridization analysis. Cancer Genet Cytogenet 146: 16-21, 2003. (Pubitemid 37117429)
22. Schneider G, Weber A, Zechner U, et al: GADD45alpha is highly expressed in pancreatic ductal adenocarcinoma cells and required for tumor cell viability. Int J Cancer 118: 2405-2411, 2006.
23. Parvaresch S, Yesilkaya T, Baer K, Al-Hasani H and Klein HW: 14-3-3 binding to the IGF-1 receptor is mediated by serine autophosphorylation. FEBS Lett 532: 357-362, 2002. (Pubitemid 35441373)
24. Nakamura K, Hongo A, Kodama J, Miyagi Y, Yoshinouchi M and Kudo T: Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines. Cancer Res 60: 760-765, 2000. (Pubitemid 30094579)
25. Spence SL, Dey BR, Terry C, Albert P, Nissley P and Furlanetto RW: Interaction of 14-3-3 proteins with the insulin-like growth factor I receptor (IGFIR): evidence for a role of 14-3-3 proteins in IGFIR signaling. Biochem Biophys Res Commun 312: 1060-1066, 2003. (Pubitemid 37490923)
26. Fu H, Subramanian RR and Masters SC: 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40: 617-647, 2000. (Pubitemid 30340695)
27. Craparo A, Freund R and Gustafson TA: 14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner. J Biol Chem 272: 11663-11669, 1997. (Pubitemid 27184180)
28. Takashima T, Fujiwara Y, Higuchi K, et al: PPAR-γ ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity. Int J Oncol 19: 465-471, 2001.
29. Yang WL and Frucht H: Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells. Carcinogenesis 22: 1379-1383, 2001.
30. Hall JM and McDonnell DP: The molecular mechanisms underlying the proinflammatory actions of thiazolidinediones in human macrophages. Mol Endocrinol 21: 1756-1768, 2007. (Pubitemid 47173789)
31. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P and Evans RM: PPAR-gamma dependent and independent effects on macrophage- gene expression in lipid metabolism and inflammation. Nat Med 7: 48-52, 2001. (Pubitemid 32095641)
32. Marx N, Kehrle B, Kohlhammer K, et al: PPAR activators as anti-inflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis. Circ Res 90: 703-710, 2002. (Pubitemid 34640890)
33. Shankaranarayanan P and Nigam S: IL-4 induces apoptosis in A549 lung adenocarcinoma cells: evidence for the pivotal role of 15- hydroxyeicosatetraenoic acid binding to activated peroxisome proliferator-activated receptor gamma transcription factor. J Immunol 170: 887-894, 2003. (Pubitemid 36070542)
34. Eichele K, Ramer R and Hinz B: R(+)-methanandamide-induced apoptosis of human cervical carcinoma cells involves a cyclo oxygenase-2-dependent pathway. Pharm Res 26: 346-355, 2009.